OptiBiotix to bring cholesterol reduction product to India with new agreement
The agreement was signed with Akums Drugs and Pharmaceuticals Ltd, a leading contract manufacturer of food and drug supplements in India
Company
OptiBiotix Health PLC
LON:OPTI
OptiBiotix Health Plc is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing and commercialising technologies that modulate the human microbiome – the collective genome of the microbes in the body – the company identifies and develops prebiotic formulations and compounds for use in food ingredients and supplements that can impact on human physiology and metabolism, deriving potential health benefits.
574 stories · page 16 of 29
Investments and investor services
FTSE 100 closes higher as Wall Street struggles for direction
The UK blue-chip benchmark closed around 11 points higher at 7,334..
Archive
Proactive news snapshot: Challenger Acquisitions, SDX Energy, Greencoat UK Wind …
A glance at some of the day's highlights from the Proactive Investors newswire
Nanoco Group on the front foot after receiving £1.8mln payment from US partner
A look at some of the top risers and fallers in London on Tuesday
OptiBiotix to present new products and research data at leading industry trade show next week
OptiBiotix will show off new product concepts for its SlimBiome weight loss ingredient, as well as the latest data from human studies of its LPLDL cholesterol and blood pressure-reducing probiotic
FTSE 100 closes slightly in red; Shire biggest gainer
FTSE 100 closed 1.39 points lower at 7,565, while FTSE 250 went the other way
Archive
Proactive news snapshot: OptiBiotix Health, Kromek Group, Union Jack Oil …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Cora Gold leads small cap risers as it boasts “exciting high grade results”
A look at some of the biggest risers and fallers in London on Tuesday.
OptiBiotix shares jump amid media interest generated by potential US commercial partner
OptiBiotix said it can confirm it is in discussions with Seed Heath to agree commercial terms for the use of its LP-LDL strain in Seed's products in preparation for a May launch in the US
Investments and investor services
FTSE 100 calls Mayday but manages to end the day safely in positive territory
Poor manufacturing stats raise worries over the British economy, the PMI measure for April was the lowest for 17-months..
Proactive news snapshot: Redx Pharma, Tissue Regenix, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Tern shares spike up as holding company extends security capability for Microsoft’s internet of things platform
A look at some of the biggest risers and fallers in London on Tuesday
OptiBiotix signs agreement with Cambridge Commodities to distribute SlimBiome in the UK
The AIM-listed firm said the agreement extends SlimBiome’s commercial reach into new application areas where Cambridge Commodities Ltd has specific sector expertise, such as sports, health & wellbeing and the ingredients sectors
FTSE 100 extends gains in the final sessions
Stocks consolidated gains at the death with bid stock Shire the best performing blue-chip
SkinBioTheraputics “significantly undervalued” despite having demonstrated significant progress
In a note to clients initiating coverage on SkinBio, the joint ‘house’ broker noted that, as the skin microbiome group operates in a new therapeutic area, there is little market data in the sector
Archive
Proactive news snapshot: ValiRx, Stratex International, ANGLE …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
MyCelx ups full-year guidance as new order and equipment sale bring in US$2.7mln
MYCELX now expects full-year revenues to be in the range of US$16-17mln after the new order and equipment sale
OptiBiotix appoints new head of online sales and marketing to develop firm’s web presence
The AIM-listed firm said Steven Riley will lead the development of the Optibiotix online presence as another revenue generating business in its own right
FTSE 100 closes in the black as Shire surges; tobacco stocks drift lower
Shire shares ended 5.89% up as the group received and rejected a takeover approach from Japan's Takeda Pharma